CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award | +90,000 | 165,000 | ||
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Shares withheld for taxes | −5,428 | $2.65 | $14K | 159,572 |
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award · Non-Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-03-07 | BRAENDER LORI J Chief Legal Officer | Grant or award | +110,000 | 423,231 | ||
| 2025-03-07 | BRAENDER LORI J Chief Legal Officer | Shares withheld for taxes | −9,592 | $2.65 | $25K | 413,639 |
| 2025-03-07 | BRAENDER LORI J Chief Legal Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-03-07 | Boyd Peter E. See Remark | Grant or award | +80,000 | 317,628 | ||
| 2025-03-07 | Boyd Peter E. See Remark | Shares withheld for taxes | −6,624 | $2.65 | $18K | 311,004 |
| 2025-03-07 | Boyd Peter E. See Remark | Grant or award · Non-Qualified Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-03-07 | Barber Daniel President and CEO | Grant or award | +272,000 | 1,098,478 | ||
| 2025-03-07 | Barber Daniel President and CEO | Shares withheld for taxes | −29,307 | $2.65 | $78K | 1,069,171 |
| 2025-03-07 | Barber Daniel President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +408,000 | 408,000 | ||
| 2024-12-02 | BRATTON DOUGLAS K 10% owner | Gift | −40,000 | 199,841 | ||
| 2024-11-26 | Jung Cassie Chief Operating Officer | Sale | −44 | $4.87 | $214 | 0 |
| 2024-08-09 | Kraus Carl N Chief Medical Officer | Shares withheld for taxes | −10,819 | $3.43 | $37K | 251,681 |
| 2024-06-20 | MORRIS TIMOTHY E Director | Grant or award · Stock Option (right to purchase) | +38,000 | 38,000 | ||
| 2024-06-20 | Taglietti Marco Director | Grant or award · Stock Option (Right to Purchase) | +38,000 | 38,000 | ||
| 2024-06-20 | BROWN GREGORY B Director | Grant or award · Stock Option (Right to Purchase) | +38,000 | 38,000 | ||
| 2024-06-20 | Krop Julie Director | Grant or award · Stock Option (Right to Purchase) | +38,000 | 38,000 | ||
| 2024-06-20 | Cochran John Director | Grant or award · Stock Option (Right to Purchase) | +38,000 | 38,000 |
Page 7 of 24 · 462 trades